Peter R Galle, MD
University Medical Center, Mainz, Germany · Germany - Universitätsmedizin Mainz · I. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peter R Galle, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:26 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04777851 · Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7Translational Research in Oncology · terminated · Carcinoma, Hepatocellular · study chair
- Ph3NCT02612428 · Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILDVital Therapies, Inc. · terminated · Acute Alcoholic Hepatitis · principal investigator
- N/ANCT02526732 · Hepatic Inflammation and Physical Performance in Patients With NASHPriv.-Doz. Dr. J. Schattenberg · completed · Non-alcoholic Fatty Liver Disease · study director
- Ph3NCT00352404 · Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated DysplasiaJohannes Gutenberg University Mainz · completed · Ulcerative Colitis, Intraepithelial Neoplasia, Cancer · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.